产品介绍 |
CPI-613是Lipoate类似物,能抑制丙酮酸脱氢酶(PDH)和α-酮戊二酸脱氢酶。 |
备注 |
CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism. Phase 2. |
生化机理 |
CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. CPI-613 is an E1α pyruvate dehydrogenase (PDH) modulator that prevents cancer cells from metabolizing glucose for energy. CPI-613 has been granted orphan drug status by the US FDA for pancreatic cancer. |
别名 |
6,8-双(苄硫基)辛酸;CPI 613;CPI613; 6,8-Bis[(phenylmethyl)thio-octanoic acid ;6,8-bis(benzylthio)octanoic acid; |